Comparative Efficacy and Safety Study in Patients With Active Ulcerative Colitis.

Trial Profile

Comparative Efficacy and Safety Study in Patients With Active Ulcerative Colitis.

Completed
Phase of Trial: Phase III

Latest Information Update: 22 Feb 2016

At a glance

  • Drugs Mesalazine (Primary)
  • Indications Ulcerative colitis
  • Focus Therapeutic Use
  • Most Recent Events

    • 22 Feb 2016 Primary endpoint has been met. (Reduction degree of UC-DAI), as per an article published in the Advances in Therapy.
    • 22 Feb 2016 Results published in the Advances in Therapy
    • 01 Mar 2013 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top